Robert M. Scarborough

Statistics

Publications

Citations

6.6K

H-Index

Active since

1977

Affiliations

Millennium Engineering and Integration (United States)(Current)

Portola Pharmaceuticals (United States)

Eli Lilly (United States)

Planet Biotechnology (United States)

Monell Chemical Senses Center

Robert M. Scarborough is an author at Millennium Engineering and Integration (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1977–2009

Publications

Physiological Role of Silent Receptors of Atrial Natriuretic Factor

Thomas Maack, Muneya Suzuki, Fernando Antônio de Almeida et al. · Science · 1987 · 940 citations

Medicine, Pharmacology, Physiology +14

Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.

Forrest Fuller, J G Porter, Ann Arfsten et al. · Journal of Biological Chemistry · 1988 · 480 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.

Robert M. Scarborough, M.A. Naughton, Wei-Ning Teng et al. · Journal of Biological Chemistry · 1993 · 374 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

Medicine, Oncology, Pharmacology +10

Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms.

Robert M. Scarborough, Jack W. Rose, M.A. Naughton et al. · Journal of Biological Chemistry · 1993 · 295 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

1–5 of 79